Stent Retriever Articles & Analysis
6 news found
“Medical therapy is currently suboptimal for these patients, so there can be a huge benefit for devices that emergently restore blood flow while minimizing the potential for harm.” Existing stent retrievers lack any adjustability– they open passively and are pulled from the brain fully expanded. ...
Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System, a patented device designed to treat long, diffuse and severely calcified infrapopliteal disease. The system allows for uniform expansion of the stent to maximize lumen diameter and ...
Reflow Medical, Inc. announces that it has completed patient enrollment in the DEEPER OUS clinical trial (NCT03807531) for the company’s Temporary Spur Stent System, a novel device that features a retrievable stent designed for complex infrapopliteal disease. 106 patients have now been enrolled in the prospective, nonrandomized trial in ...
“This is a historical trial which is evaluating what I consider to be the biggest breakthrough in endovascular stroke treatment since the advent of stent retrievers over a decade ago,” said Dr. Raul Nogueira, Professor of Neurology and Radiology at Emory University School of Medicine, Atlanta, Ga., and Principal Investigator of the Imperative Trial. ...
The clot may be removed by trapping it in a stent-retriever (mechanical), by sucking out the clot through the catheter (aspiration), or the neurointerventionalist may combine both ...
ByBIOMODEX
Reflow Medical, Inc., a California-based medical device company, has enrolled the first patients in A Non-Randomized Pilot Study of the Temporary Spur Stent System for the Treatment of Lesions Located in the InfraPoplitEal Arteries Using a LIMUS-base Drug-coated Balloon (DEEPER LIMUS). ...